South Korea Bacteriophages Therapy Market to 2032
Overview
The South Korea Bacteriophages Therapy Market is expected to reach a 1.20 USD Million by 2032 and is projected to grow at a CAGR of 10.99% from 2025 to 2032.
Revenue, 2024 (USD Million)
0.69
Forecast, 2032 (USD Million)
1.20
CAGR, 2024 - 2032
10.99%
Report Coverage
South Korea
South Korea Bacteriophages Therapy Market 2018-2032 USD Million
South Korea Bacteriophages Therapy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 0.69 USD Million
- Projected Market Size (2032): 1.20 USD Million
- CAGR (2025-2032): 10.99%
Key Findings of South Korea Bacteriophages Therapy Market
- The South Korea Bacteriophages Therapy Market was valued at 0.69 USD Million in 2024.
- The South Korea Bacteriophages Therapy Market is likely to grow at a CAGR of 10.99% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Lytic in Type Segment accounted for the largest share of the market with a revenue of 0.64 USD Million
- The fastest growing segment Supperative Skin Infections in Application Segment grew Fastest with a CAGR of 11.69% during the forecast period from 2024 to 2032.
South Korea Bacteriophages Therapy Market Scope
South Korea Bacteriophages Therapy Market Segmentation & Scope
Distribution Channel
- Third Party Distributors
- Direct Tender
End User
- Others
- Academic Research & Institutes
- Speciality Clinics
- Hospitals
Route Of Administration
- Others
- Parenteral
- Dermal
- Oral
Application
- Lung And Pleural Infections
- Supperative Skin Infections
- Others
- Bacterial Dysentery
- Infections Of Skin And Nasal Mucosa
- Postoperative Wound Infections
Base
- Water-Soluble Jelly Base
- Sterile Broth Culture
Type
- Lysogenic
- Lytic
Target
- Salmonella
- Streptococcus
- Pseudomonas
- Others
- Escherichia coli
- Staphylococcus
South Korea Bacteriophages Therapy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 0.69 USD Million |
| Market Value in 2032 | 1.20 USD Million |
| CAGR (2025-2032) | 10.99% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Distribution Channel,End User,Route Of Administration,Application,Base,Type,Target |
Regional Insights:
-
Leading Market (2024-2032): South Korea, leading in terms of revenue 0.69 USD Million in 2024
- Key Country: South Korea, leading in terms of revenue with value of 0.69 USD Million in 2024.
Segments and Scope
-
South Korea Bacteriophages Therapy Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in South Korea Bacteriophages Therapy Market to 2032 with a revenue of 0.63 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in South Korea Bacteriophages Therapy Market to 2032 with a Growth rate of 11.14 % in forecast period 2025-2032.
-
South Korea Bacteriophages Therapy Market to 2032, By End User
- Hospitals is the largest segment in South Korea Bacteriophages Therapy Market to 2032 with a revenue of 0.25 USD Million in the year 2024.
- Speciality Clinics is the Fastest growing segment in South Korea Bacteriophages Therapy Market to 2032 with a Growth rate of 10.60 % in forecast period 2025-2032.
-
South Korea Bacteriophages Therapy Market to 2032, By Route Of Administration
- Oral is the largest segment in South Korea Bacteriophages Therapy Market to 2032 with a revenue of 0.30 USD Million in the year 2024.
- Dermal is the Fastest growing segment in South Korea Bacteriophages Therapy Market to 2032 with a Growth rate of 10.55 % in forecast period 2025-2032.
-
South Korea Bacteriophages Therapy Market to 2032, By Application
- Postoperative Wound Infections is the largest segment in South Korea Bacteriophages Therapy Market to 2032 with a revenue of 0.21 USD Million in the year 2024.
- Supperative Skin Infections is the Fastest growing segment in South Korea Bacteriophages Therapy Market to 2032 with a Growth rate of 11.52 % in forecast period 2025-2032.
-
South Korea Bacteriophages Therapy Market to 2032, By Base
- Sterile Broth Culture is the largest segment in South Korea Bacteriophages Therapy Market to 2032 with a revenue of 0.49 USD Million in the year 2024.
- Sterile Broth Culture is the Fastest growing segment in South Korea Bacteriophages Therapy Market to 2032 with a Growth rate of 11.20 % in forecast period 2025-2032.
-
South Korea Bacteriophages Therapy Market to 2032, By Type
- Lytic is the largest segment in South Korea Bacteriophages Therapy Market to 2032 with a revenue of 0.64 USD Million in the year 2024.
- Lytic is the Fastest growing segment in South Korea Bacteriophages Therapy Market to 2032 with a Growth rate of 11.17 % in forecast period 2025-2032.
-
South Korea Bacteriophages Therapy Market to 2032, By Target
- Staphylococcus is the largest segment in South Korea Bacteriophages Therapy Market to 2032 with a revenue of 0.19 USD Million in the year 2024.
- Escherichia coli is the Fastest growing segment in South Korea Bacteriophages Therapy Market to 2032 with a Growth rate of 10.64 % in forecast period 2025-2032.
South Korea Bacteriophages Therapy Market Company Share Analysis
| Company Name |
|
||
| Microgen | |||
| MICREOS | |||
| Intralytix, Inc. | |||
| LOCUS BIOSCIENCES, INC. | |||
| Phagelux, Inc. | |||
South Korea Bacteriophages Therapy Market Geographical Sales Distribution, 2018-2032 USD Million
South Korea Bacteriophages Therapy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Korea Bacteriophages Therapy Market is segmented based on Segmentation Distribution Channel,End User,Route Of Administration,Application,Base,Type,Target.
South Korea Bacteriophages Therapy Market was valued at USD 0.69(Revenue in USD Million) in 2020.
South Korea Bacteriophages Therapy Market is projected to grow at a CAGR of 10.99% during the forecast period of 2024 to 2032.
The Lytic segment is expected to dominate the South Korea Bacteriophages Therapy Market, holding a largest market share of 0.64 USD Million in 2024
South Korea Bacteriophages Therapy Market Scope
South Korea Bacteriophages Therapy Market Segmentation & Scope
Distribution Channel
- Third Party Distributors
- Direct Tender
End User
- Others
- Academic Research & Institutes
- Speciality Clinics
- Hospitals
Route Of Administration
- Others
- Parenteral
- Dermal
- Oral
Application
- Lung And Pleural Infections
- Supperative Skin Infections
- Others
- Bacterial Dysentery
- Infections Of Skin And Nasal Mucosa
- Postoperative Wound Infections
Base
- Water-Soluble Jelly Base
- Sterile Broth Culture
Type
- Lysogenic
- Lytic
Target
- Salmonella
- Streptococcus
- Pseudomonas
- Others
- Escherichia coli
- Staphylococcus
Frequently Asked Questions
The South Korea Bacteriophages Therapy Market is segmented based on Segmentation Distribution Channel,End User,Route Of Administration,Application,Base,Type,Target.
South Korea Bacteriophages Therapy Market was valued at USD 0.69(Revenue in USD Million) in 2020.
South Korea Bacteriophages Therapy Market is projected to grow at a CAGR of 10.99% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Bacteriophages Therapy Market for final year is USD 1.20 (USD Million).
South Korea Bacteriophages Therapy Market Company Profiling
Frequently Asked Questions
The South Korea Bacteriophages Therapy Market is segmented based on Segmentation Distribution Channel,End User,Route Of Administration,Application,Base,Type,Target.
South Korea Bacteriophages Therapy Market was valued at USD 0.69(Revenue in USD Million) in 2020.
South Korea Bacteriophages Therapy Market is projected to grow at a CAGR of 10.99% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Bacteriophages Therapy Market for final year is USD 1.20 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.